Claims
- 1. A method for treating cancer cachexia in a mammal by inhibiting lipolytic activity of lipolytic factors which comprises administering to said mammal in need of such treatment, an effective amount of 5,8,11,14,17-eicosapentaenoic acid or a pharmaceutically acceptable salt or ester thereof; without the primary aim of said method being the treatment of cancer.
- 2. The method of claim 1 wherein the EPA 5,8,11,14,17-eicosapenaenoic acid is of at least 90% purity.
- 3. The method of claim 1 wherein the EPA 5,8,11,14,17-eicosapentaenoic acid is about 95% pure.
- 4. The method of claim 1 wherein the EPA 5,8,11,14,17-eicosapentaenoic acid is substantially free of any other polyunsaturated fatty acids.
Priority Claims (1)
Number |
Date |
Country |
Kind |
890636 |
Mar 1989 |
GBX |
|
Parent Case Info
This is a continuation of application Ser. No. 07/938,534, filed on Sep. 2, 1992, which was abandoned, which is a continuation of application Ser. No. 07/548,894, filed as PCT/GB90/00425, Mar. 20, 1990, which was abandoned.
US Referenced Citations (3)
Number |
Name |
Date |
Kind |
4835183 |
Yamatsu et al. |
May 1989 |
|
4954525 |
Yamatsu et al. |
Sep 1990 |
|
4960795 |
Salte et al. |
Oct 1990 |
|
Foreign Referenced Citations (8)
Number |
Date |
Country |
8319333 |
Sep 1983 |
AUX |
122597 |
Aug 1987 |
CAX |
175468 |
Aug 1984 |
EPX |
0378824 |
Jul 1990 |
EPX |
3303925 |
Dec 1988 |
JPX |
2134782 |
Aug 1984 |
GBX |
2223943 |
Apr 1990 |
GBX |
0385859 |
Sep 1990 |
GBX |
Non-Patent Literature Citations (5)
Entry |
Laustiola et al, Biochimica et Biophysica Acta, vol. 889, 1986, Elsevier Science Publishers B.V. |
Karmall et al, J.N.C.J., vol. 73, No. 2, Aug., 1984. |
Begin et al, Prostaglandins Leukotrienes and Medicine, vol. 19, 1985. |
Booyens et al, IRCS Medical Science, vol. 14, No. 4, 1986. |
Steven et al, J. Enzym. Inhib., vol. 1, No. 2, 1987. |
Continuations (2)
|
Number |
Date |
Country |
Parent |
938534 |
Sep 1992 |
|
Parent |
548894 |
Jul 1990 |
|